Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Takeda
Paul G Richardson; Shaji K Kumar; Tamás Masszi; Norbert Grzasko; Nizar J Bahlis; Markus Hansson; Luděk Pour; Irwindeep Sandhu; Peter Ganly; Bartrum W Baker; Sharon R Jackson; Anne-Marie Stoppa; Peter Gimsing; Laurent Garderet; Cyrille Touzeau; Francis K Buadi; Jacob P Laubach; Michele Cavo; Mohamed Darif; Richard Labotka; Deborah Berg; Philippe Moreau